Compositions and methods for cell transformation
First Claim
Patent Images
1. A method of enhancing the transformability of a host cell comprising contacting a host cell with a compound of the formula (I):
- ##STR2## in which R1 can be an H, OH, OR5, NH2, NHR6 or NR6 R7 ;
R2 and R3 may be the same or different and can be an H, OH or OR5 ;
R4 can be CONH2, CONHR6, CONR6 R7, CH2 NH2, CH2 NHR6, CH2 NR6 R7, CO2 --Y--NH2, CO2 --Y--NHR6, or CO2 --Y--NR6 R7 ;
R5 is a protected or unprotected glycosyl moiety comprising 1-10 monosaccharide units in which the glycosidic linkage at the anomeric carbon atom of each monosaccharide unit is independently alpha or beta;
NH2, NHR6, and NR6 R7 represent an unsubstituted amino group, a monosubstituted amino group, and a disubstituted amino group, respectively, in which R6 and R7 may be the same or different and represent a hydrocarbon group comprising 1-15 carbon atoms substituted with one or more unsubstituted, monosubstituted or disubstituted amino groups;
Y represents a linear or branched alkylene group comprising 1-10 carbon atoms;
n is an integer from 0-10;
or its acid addition or quaternary ammonium salt;
provided that said compound comprises at least one R6 group as defined above; and
(b) allowing said compound to remain in contact with said host cell while exposing said host cell to transforming nucleic acid.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention relates to methods and compositions for the transformation of cells. In particular, compositions and methods are disclosed which include combinations of the nucleic acid of interest and polyhydroxylated or polyglycosylated steroid molecules. Most preferably, exogenous or endogenous nucleic acid is contacted with the cell in the presence of a bile acid (e.g., cholic acid) derivatized with an amine-containing side chain.
-
Citations
3 Claims
-
1. A method of enhancing the transformability of a host cell comprising contacting a host cell with a compound of the formula (I):
- ##STR2## in which R1 can be an H, OH, OR5, NH2, NHR6 or NR6 R7 ;
R2 and R3 may be the same or different and can be an H, OH or OR5 ; R4 can be CONH2, CONHR6, CONR6 R7, CH2 NH2, CH2 NHR6, CH2 NR6 R7, CO2 --Y--NH2, CO2 --Y--NHR6, or CO2 --Y--NR6 R7 ; R5 is a protected or unprotected glycosyl moiety comprising 1-10 monosaccharide units in which the glycosidic linkage at the anomeric carbon atom of each monosaccharide unit is independently alpha or beta; NH2, NHR6, and NR6 R7 represent an unsubstituted amino group, a monosubstituted amino group, and a disubstituted amino group, respectively, in which R6 and R7 may be the same or different and represent a hydrocarbon group comprising 1-15 carbon atoms substituted with one or more unsubstituted, monosubstituted or disubstituted amino groups; Y represents a linear or branched alkylene group comprising 1-10 carbon atoms; n is an integer from 0-10; or its acid addition or quaternary ammonium salt;
provided that said compound comprises at least one R6 group as defined above; and(b) allowing said compound to remain in contact with said host cell while exposing said host cell to transforming nucleic acid. - View Dependent Claims (2, 3)
- ##STR2## in which R1 can be an H, OH, OR5, NH2, NHR6 or NR6 R7 ;
Specification